It was shown possible to change the cytotoxic properties of the antitumor antibiotic bleomycetin by its binding to Bacillus intermedius RNAse. The complexing lowered the antibiotic effect on DNA in the cells of the human amnion. At the same time the experiments with human red blood cells indicated that RNAse of B.intermedius in complex with bleomycetin - Fe (II) increased the antibiotic capacity for the cell membrane break down
© 2014 Elsevier B.V. All rights reserved. The cytotoxic effects of Bacillus intermedius RNase (binas...
The cancer chemotherapeutic drug, bleomycin, is clinically used to treat several neoplasms including...
Cytotoxic ribonucleases (RNAses) are known to be perspective drugs for cancer therapy. The extension...
It was shown possible to change the cytotoxic properties of the antitumor antibiotic bleomycetin by ...
In a concentration providing the maximum in vivo antitumor action, 'Bacillus intermedius' RNAase had...
Modified derivatives of RNAse from Bacillus intermedius differing in the aggregate enzymatic, physic...
Some microbial ribonucleases (RNases) demonstrate selective cytotoxic effect against a wide range of...
Ribonuclease (RNase) treatment represents a novel mechanism based approach to anticancer therapy as ...
© 2016, Pleiades Publishing, Ltd.Some microbial ribonucleases (RNases) demonstrate selective cytotox...
Microbial ribonucleases possess a broad spectra of biological activities, demonstrating stimulating ...
The antiproliferative action of the guanine-specific ribonuclease secreted by Bacillus intermedius (...
AbstractBleomycin is a clinically used antitumor antibiotic long thought to function therapeutically...
Many ribonucleases (RNases) are highly cytotoxic. In some cases, they attack selectively malignant c...
© 2014 Elsevier B.V. All rights reserved. The cytotoxic effects of Bacillus intermedius RNase (binas...
The cancer chemotherapeutic drug, bleomycin, is clinically used to treat several neoplasms including...
Cytotoxic ribonucleases (RNAses) are known to be perspective drugs for cancer therapy. The extension...
It was shown possible to change the cytotoxic properties of the antitumor antibiotic bleomycetin by ...
In a concentration providing the maximum in vivo antitumor action, 'Bacillus intermedius' RNAase had...
Modified derivatives of RNAse from Bacillus intermedius differing in the aggregate enzymatic, physic...
Some microbial ribonucleases (RNases) demonstrate selective cytotoxic effect against a wide range of...
Ribonuclease (RNase) treatment represents a novel mechanism based approach to anticancer therapy as ...
© 2016, Pleiades Publishing, Ltd.Some microbial ribonucleases (RNases) demonstrate selective cytotox...
Microbial ribonucleases possess a broad spectra of biological activities, demonstrating stimulating ...
The antiproliferative action of the guanine-specific ribonuclease secreted by Bacillus intermedius (...
AbstractBleomycin is a clinically used antitumor antibiotic long thought to function therapeutically...
Many ribonucleases (RNases) are highly cytotoxic. In some cases, they attack selectively malignant c...
© 2014 Elsevier B.V. All rights reserved. The cytotoxic effects of Bacillus intermedius RNase (binas...
The cancer chemotherapeutic drug, bleomycin, is clinically used to treat several neoplasms including...
Cytotoxic ribonucleases (RNAses) are known to be perspective drugs for cancer therapy. The extension...